1. Home
  2. RVNC vs NAT Comparison

RVNC vs NAT Comparison

Compare RVNC & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • NAT
  • Stock Information
  • Founded
  • RVNC 1999
  • NAT 1995
  • Country
  • RVNC United States
  • NAT Bermuda
  • Employees
  • RVNC N/A
  • NAT N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • NAT Marine Transportation
  • Sector
  • RVNC Health Care
  • NAT Consumer Discretionary
  • Exchange
  • RVNC Nasdaq
  • NAT Nasdaq
  • Market Cap
  • RVNC 599.6M
  • NAT 641.0M
  • IPO Year
  • RVNC 2014
  • NAT 1997
  • Fundamental
  • Price
  • RVNC $3.84
  • NAT $2.99
  • Analyst Decision
  • RVNC Buy
  • NAT Hold
  • Analyst Count
  • RVNC 10
  • NAT 2
  • Target Price
  • RVNC $10.23
  • NAT $3.75
  • AVG Volume (30 Days)
  • RVNC 2.9M
  • NAT 2.4M
  • Earning Date
  • RVNC 11-07-2024
  • NAT 12-02-2024
  • Dividend Yield
  • RVNC N/A
  • NAT 16.03%
  • EPS Growth
  • RVNC N/A
  • NAT N/A
  • EPS
  • RVNC N/A
  • NAT 0.29
  • Revenue
  • RVNC $256,945,000.00
  • NAT $364,249,000.00
  • Revenue This Year
  • RVNC $20.36
  • NAT N/A
  • Revenue Next Year
  • RVNC $31.66
  • NAT $11.06
  • P/E Ratio
  • RVNC N/A
  • NAT $10.34
  • Revenue Growth
  • RVNC 25.82
  • NAT N/A
  • 52 Week Low
  • RVNC $2.30
  • NAT $2.95
  • 52 Week High
  • RVNC $9.75
  • NAT $4.64
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 34.28
  • NAT 33.45
  • Support Level
  • RVNC $3.64
  • NAT $2.97
  • Resistance Level
  • RVNC $4.37
  • NAT $3.12
  • Average True Range (ATR)
  • RVNC 0.33
  • NAT 0.10
  • MACD
  • RVNC -0.11
  • NAT -0.00
  • Stochastic Oscillator
  • RVNC 18.39
  • NAT 10.29

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About NAT Nordic American Tankers Limited

Nordic American Tankers Ltd owns and operates double hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters pursuant to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.

Share on Social Networks: